Your search returned 2 results.

Results
	1.	Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial. [electronic resource] by Earl, Helena M Hiller, Louise Dunn, Janet A Blenkinsop, Clare Grybowicz, Louise Vallier, Anne-Laure Abraham, Jean Thomas, Jeremy Provenzano, Elena Hughes-Davies, Luke Gounaris, Ioannis McAdam, Karen Chan, Stephen Ahmad, Rizvana Hickish, Tamas Houston, Stephen Rea, Daniel Bartlett, John Caldas, Carlos Cameron, David A Hayward, Larry Producer: 20150831 In: The Lancet. Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial. [electronic resource] by Thomas, Jeremy St John Provenzano, Elena Hiller, Louise Dunn, Janet Blenkinsop, Clare Grybowicz, Louise Vallier, Anne-Laure Gounaris, Ioannis Abraham, Jean Hughes-Davies, Luke McAdam, Karen Chan, Stephen Ahmad, Rizvana Hickish, Tamas Houston, Stephen Rea, Daniel Caldas, Carlos Bartlett, John Ms Cameron, David Allan Hayward, Richard Laurence Earl, Helena Margaret Producer: 20180503 In: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)